Is Lorazepam Safe for Sleep? What Menopausal Women Should Know

Aug 21 2026

If you watched season 3 of The White Lotus, you probably noticed how often Victoria Ratliff reached for lorazepam. A recent Vogue essay about the show’s lorazepam discourse struck a nerve for good reason: many midlife women are asking the same question at home. When hot flashes, 3 a.m. wake-ups, anxiety, and hormonal shifts pile up, lorazepam can look like a practical answer. But when people ask whether lorazepam is safe for sleep, the real answer is more complicated. It may help in the short term, but it is rarely the best long-term solution for menopause-related insomnia, and for many women, the downsides start to outweigh the benefit fast.

The short answer

Lorazepam can make you sleepy quickly, which is why it is sometimes used when sleep trouble is tied to anxiety or acute stress.
It is not a good nightly long-term strategy for most menopausal women.
Regular use can lead to tolerance, dependence, rebound insomnia, next-day fog, and higher fall risk over time.
Menopause-related insomnia often responds better to root-cause treatment such as CBT-I, hot flash treatment, and a full sleep evaluation.

What Is Lorazepam and How Does It Work?

Lorazepam, commonly known by the brand name Ativan, is a benzodiazepine. It works by enhancing the effects of GABA, a calming neurotransmitter in the brain, which is why it can reduce anxiety, relax muscles, and create sedation. That sedating effect is exactly why some women are given lorazepam when sleep feels impossible. A StatPearls review on lorazepam explains the mechanism clearly, and the current Ativan prescribing information makes another important point: the drug’s core indication is anxiety, with dosing guidance that also includes insomnia related to anxiety or transient situational stress.

That distinction matters. If your insomnia is being driven by night sweats, sleep apnea, circadian disruption, conditioned arousal, or chronic menopause-related insomnia, lorazepam may make you drowsy without addressing the real reason you are awake. It can feel like relief, but that does not mean it is solving the problem.

The label is also clear that benzodiazepines are not meant to drift into casual long-term nightly use. The Ativan label states that benzodiazepines should generally be prescribed for short periods, often about two to four weeks, with reevaluation rather than automatic continuation.

Why Menopausal Women Are More Vulnerable to the Downsides

Menopause is not just a bad sleep season. It changes the biology around sleep. A large review of sleep and the menopausal transition found that sleep disturbance affects about 40% to 60% of menopausal women. Falling estrogen levels are linked with hot flashes, sweating, mood changes, and nighttime awakenings, all of which can fragment sleep.

That creates a setup many women know well. You are exhausted, but also wired. You wake hot, anxious, or frustrated. Your doctor wants to help. A fast-acting medication seems reasonable. The problem is that menopause can also come with brain fog, rising sleep apnea risk, mood symptoms, and bone loss. So the same medication that helps you fall asleep tonight may amplify a different midlife vulnerability tomorrow. After menopause, women also become more vulnerable to bone loss and fracture, which makes medication-related dizziness or unsteadiness more consequential.

Risks of Long-Term Lorazepam Use for Sleep

1. Tolerance can creep in

The same dose may stop feeling as effective over time. The Ativan prescribing information notes that tolerance can develop with continued therapy. That is how a short-term sleep aid can quietly become a long-term cycle.

2. Dependence and withdrawal are real risks

Benzodiazepines can cause physical dependence. The DailyMed lorazepam medication guide warns against stopping abruptly because withdrawal can include severe symptoms, including seizures in some cases. Even after recommended doses, rebound insomnia can appear quickly.

3. Your thinking may feel slower, not sharper

Menopause already comes with its own version of mental fuzziness for many women. Adding a sedating benzodiazepine can worsen daytime grogginess, short-term memory problems, and reduced alertness. The 2023 AGS Beers Criteria specifically flags benzodiazepines for increasing cognitive impairment risk in older adults.

4. Fall and fracture risk matter more in midlife than many women realize

Benzodiazepines raise the risk of falls and fractures in older adults, and postmenopausal bone loss raises the stakes of that risk. Even for women who do not think of themselves as older, this becomes more relevant as they move through their 50s and beyond.

5. You may sleep longer without sleeping better

A systematic review of benzodiazepines and sleep architecture found that these drugs can reduce REM sleep and decrease deeper slow-wave sleep while increasing stage 2 sleep. In other words, sedation is not identical to restorative sleep. You may get more hours in bed and still wake feeling unrefreshed.

There are also ongoing questions about long-term cognitive outcomes. Some observational studies have raised concern about dementia risk, but newer reviews say the evidence is weak or mixed. That uncertainty should not be used to minimize the medication’s risks, but the clearer concerns remain dependence, daytime impairment, and fall risk.

What the Research Says About Benzodiazepines and Sleep

The research tells a nuanced story. Sleep medications can help some people in the short term. But the big insomnia guidelines do not frame nightly sedative use as the first answer for chronic insomnia.

A 2021 American Academy of Sleep Medicine guideline gives a strong recommendation for multicomponent CBT-I in adults with chronic insomnia. A separate American College of Physicians guideline recommends CBT-I as the initial treatment, with medication only considered after a discussion of benefits and harms. The AASM guideline also notes that sleep hygiene alone should not be used as the only treatment for chronic insomnia.

Midlife women deserve special attention here. In the long-running SWAN cohort study, sleep medication use among women reporting sleep disturbance increased from 2.5% to 8% over 20 years across the menopause transition. But another SWAN analysis found that women who started prescription sleep medications rated their sleep disturbances about the same after one and two years as women who did not. That does not mean medications never help. It does mean long-term reliance deserves a second look.

Safer Alternatives for Menopausal Sleep

1. CBT-I

This is the first place to look for chronic insomnia. CBT-I is not just generic sleep advice. It is a structured treatment that targets the thoughts and behaviors that keep insomnia going. The AASM guideline recommends it strongly, and a 2024 review of insomnia in postmenopausal women found meaningful benefits for menopausal women, including better sleep latency, sleep quality, and wake time after sleep onset. Dr. Matsumura’s article on why CBT-I matters in menopause is a strong next read.

2. Menopause-specific treatment when hot flashes are driving the problem

If your sleep fell apart when vasomotor symptoms arrived, hormone treatment may be part of the answer. The 2022 Menopause Society hormone therapy position statement says hormone therapy remains the most effective treatment for vasomotor symptoms and helps prevent bone loss and fracture. A 2024 postmenopausal insomnia review suggests menopausal hormone therapy can be especially relevant when insomnia is closely tied to hot flashes. Dr. Matsumura’s piece on hormone therapy and sleep covers this conversation well.

3. Sleep hygiene, but not as a solo fix

Yes, a cool bedroom, consistent wake time, reduced alcohol, less late caffeine, and fewer screens help. They just usually are not enough by themselves for entrenched insomnia. Think of these as supportive basics, not the full treatment plan.

4. Relaxation and mindfulness

Breathwork, meditation, gentle yoga, and nervous system downshifting can be useful, especially when bedtime anxiety has become part of the cycle. These work best as companions to CBT-I or broader menopause care, not as the only intervention.

5. Thoughtful supplement use

Some women benefit from melatonin or magnesium glycinate, but supplements are not risk-free or one-size-fits-all. Dosing, timing, formulation, and interactions matter. Dr. Matsumura’s guide to sleep supplements for menopausal women is a better starting point than random internet advice.

6. A fuller sleep evaluation

If you snore, gasp, wake with palpitations, or feel exhausted despite sleeping, the issue may not be insomnia alone. Sleep apnea becomes more common after menopause, and treating the wrong problem is one of the fastest ways to stay stuck.

Should You Stop Taking Lorazepam If You’re Already Using It?

Not on your own, and not abruptly.

This is the part of the conversation that needs care, not panic. If lorazepam has become part of your routine, that does not mean you did something wrong. It means you need a medically supervised plan. The lorazepam medication guide warns clearly against suddenly stopping because withdrawal can be dangerous. The taper needs to be individualized, often with gradual dose reduction and support for rebound insomnia and anxiety along the way.

The smartest tapers usually add something constructive while the medication is being reduced. That may mean CBT-I, treatment for hot flashes, therapy for anxiety, a sleep apnea workup, or a broader framework like the D.R.E.A.M. Method™ that looks at sleep from several angles instead of just asking whether you are sedated enough to get through the night.

Sleep That Actually Supports Midlife Health

Lorazepam may help some women sleep for a brief stretch, especially when anxiety is acute. But for most menopausal women, it is not the safest or strongest long-term answer. The more important question is not whether a pill can knock you out tonight. It is whether your treatment is helping you build sleep that is restorative, stable, and compatible with your health in midlife.

References